Cancer biotech ImmVirX taps Bell Potter for $20m pre-IPO

SYDNEY: The team behind ex-ASX listed biotech Viralytics – which was bought by ... read more

CSL gives up on plans to develop COVID treatment

SYDNEY: CSL has shelved plans to develop a coronavirus treatment using the plasma ... read more

Retirees are super spenders claims new research report

MELBOURNE: Senior Australians are dying without a cent of superannuation, according to new ... read more

APN flags legal action against Grocon owner

MELBOURNE: Daniel Grollo’s chances of cleanly walking away from his legacy Grocon business ... read more